Anti-Inflammatory Effect of Apigenin on LPS-Induced Pro-Inflammatory Mediators and AP-1 Factors in Human Lung Epithelial Cells

Inflammation

Volumn 39, Issue 1, 2016, Pages 138-147

  Patil, Rajeshwari H ^a   Babu, R L ^a,b   Naveen Kumar, M ^a   Kiran Kumar, K M ^a   Hegde, Shubha M ^a   Nagesh, Rashmi ^a   Ramesh, Govindarajan T ^c   Sharma, S Chidananda ^a  

^a BANGALORE UNIVERSITY   (India)

^b Karnataka State Women s University   (India)

^c NORFOLK STATE UNIVERSITY   (United States)

Author keywords

A549; AP 1 factors; apigenin; LPS; pro inflammatory mediators

Indexed keywords

APIGENIN; CYCLOOXYGENASE 2; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUNB; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN;

A549 CELL LINE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG ALVEOLUS EPITHELIUM CELL; MEDIATOR RELEASE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; CELL LINE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; RESPIRATORY MUCOSA;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APIGENIN; CELL LINE; CELL SURVIVAL; CYCLOOXYGENASE 2; CYTOKINES; EPITHELIAL CELLS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RESPIRATORY MUCOSA; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1;

EID: 84958043879     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-015-0232-z     Document Type: Article

References (44)

1. Hanada, T., and A. Yoshimura. 2002. Regulation of cytokine signaling and inflammation. Cytokine & Growth Factor Reviews 13(4–5): 413–421.
2. Vincent, J.L., Q. Sun, and M.J. Dubois. 2002. Clinical trials of immunomodulatory therapies in severe sepsis and septic shock. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 34(8): 1084–1093. doi:10.1086/339549.
3. Sparwasser, T., T. Miethke, G. Lipford, K. Borschert, H. Hacker, K. Heeg, et al. 1997. Bacterial DNA causes septic shock. Nature 386(6623): 336–337. doi:10.1038/386336a0.
4. Karima, R., S. Matsumoto, H. Higashi, and K. Matsushima. 1999. The molecular pathogenesis of endotoxic shock and organ failure. Molecular Medicine Today 5(3): 123–132. doi:10.1016/S1357-4310(98)01430-0.
5. Tobias, P.S., R.I. Tapping, and J.A. Gegner. 1999. Endotoxin interactions with lipopolysaccharide-responsive cells. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 28(3): 476–481. doi:10.1086/515163.
6. Xagorari, A., A. Papapetropoulos, A. Mauromatis, M. Economou, T. Fotsis, and C. Roussos. 2001. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. The Journal of Pharmacology and Experimental Therapeutics 296(1): 181–187.
7. Wang, H.Q., and R.C. Smart. 1999. Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion. Journal of Cell Science 112(Pt 20): 3497–3506.
8. Lantz, R.C., G.J. Chen, A.M. Solyom, S.D. Jolad, and B.N. Timmermann. 2005. The effect of turmeric extracts on inflammatory mediator production. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 12(6–7): 445–452. doi:10.1016/j.phymed.2003.12.011.
9. Tracey, K.J., Y. Fong, D.G. Hesse, K.R. Manogue, A.T. Lee, G.C. Kuo, et al. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330(6149): 662–664. doi:10.1038/330662a0.
10. Dinarello, C.A. 1997. Interleukin-1. Cytokine & Growth Factor Reviews 8(4): 253–265.
11. Papavassiliou, A.G. 1995. Transcription factors: structure, function, and implication in malignant growth. Anticancer Research 15(3): 891–894.
12. Shaulian, E., and M. Karin. 2002. AP-1 as a regulator of cell life and death. Nature Cell Biology 4(5): E131–E136. doi:10.1038/ncb0502-e131.
13. Chinenov, Y., and T.K. Kerppola. 2001. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20(19): 2438–2452. doi:10.1038/sj.onc.1204385.
14. Stafford, H.A. 1992. Flavonoid metabolism. Boca Raton: CRC Press.
15. Middleton, E. 1996. The flavonoids as potential therapeutic agents. In Immunopharmaceuticals, ed. E.S. Kimball, 227–257. Boca Raton: CRC Press.
16. Babu, R.L., M. Naveen Kumar, R.H. Patil, K.S. Devaraju, G.T. Ramesh, and S.C. Sharma. 2013. Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation. Molecular and Cellular Biochemistry 380(1–2): 143–151. doi:10.1007/s11010-013-1667-x.
17. Periyakaruppan, A., F. Kumar, S. Sarkar, C.S. Sharma, and G.T. Ramesh. 2007. Uranium induces oxidative stress in lung epithelial cells. Archives of Toxicology 81(6): 389–395. doi:10.1007/s00204-006-0167-0.
18. Eigler, A., J. Moeller, and S. Endres. 1995. Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7. Journal of Immunology (Baltimore, Md: 1950) 154(8): 4048–4054.
19. Sharma, S.C., J.W. Clemens, M.D. Pisarska, and J.S. Richards. 1999. Expression and function of estrogen receptor subtypes in granulosa cells: regulation by estradiol and forskolin. Endocrinology 140(9): 4320–4334. doi:10.1210/endo.140.9.6965.
20. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72: 248–254.
21. Murakami, A., and H. Ohigashi. 2007. Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. International Journal of Cancer Journal International du Cancer 121(11): 2357–2363. doi:10.1002/ijc.23161.
22. Levine, S.J. 1995. Bronchial epithelial cell-cytokine interactions in airway inflammation. Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 43(3): 241–249.
23. Barnes, P.J., and I. Adcock. 1993. Anti-inflammatory actions of steroids: molecular mechanisms. Trends in Pharmacological Sciences 14(12): 436–441.
24. Vane, S.J. 1998. Differential inhibition of cyclooxygenase isoforms: an explanation of the action of NSAIDs. Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases 4(5 Suppl): s3–s10.
25. Iwashita, K., M. Kobori, K. Yamaki, and T. Tsushida. 2000. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Bioscience, Biotechnology, and Biochemistry 64(9): 1813–1820. doi:10.1271/bbb.64.1813.
26. Mak, P., Y.K. Leung, W.Y. Tang, C. Harwood, and S.M. Ho. 2006. Apigenin suppresses cancer cell growth through ERbeta. Neoplasia 8(11): 896–904. doi:10.1593/neo.06538.
27. Liang, Y.C., Y.T. Huang, S.H. Tsai, S.Y. Lin-Shiau, C.F. Chen, and J.K. Lin. 1999. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20(10): 1945–1952.
28. Raso, G.M., R. Meli, G. Di Carlo, M. Pacilio, and R. Di Carlo. 2001. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sciences 68(8): 921–931.
29. Jeong, G.S., S.H. Lee, S.N. Jeong, Y.C. Kim, and E.C. Kim. 2009. Anti-inflammatory effects of apigenin on nicotine- and lipopolysaccharide-stimulated human periodontal ligament cells via heme oxygenase-1. International Immunopharmacology 9(12): 1374–1380. doi:10.1016/j.intimp.2009.08.015.
30. Murakami, A., D. Takahashi, K. Hagihara, K. Koshimizu, and H. Ohigashi. 2003. Combinatorial effects of nonsteroidal anti-inflammatory drugs and food constituents on production of prostaglandin E2 and tumor necrosis factor-alpha in RAW264.7 murine macrophages. Bioscience, Biotechnology, and Biochemistry 67(5): 1056–1062.
31. Boucher, J.L., C. Moali, and J.P. Tenu. 1999. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cellular and Molecular Life Sciences: CMLS 55(8–9): 1015–1028.
32. Patil, R.H., R.L. Babu, M. Naveen Kumar, K.M. Kiran Kumar, S.M. Hegde, G.T. Ramesh, et al. 2015. Apigenin inhibits PMA-induced expression of pro-inflammatory cytokines and AP-1 factors in A549 cells. Molecular and Cellular Biochemistry 403(1–2): 95–106. doi:10.1007/s11010-015-2340-3.
33. Chung, W.Y., J.H. Park, M.J. Kim, H.O. Kim, J.K. Hwang, S.K. Lee, et al. 2007. Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kappa B. Carcinogenesis 28(6): 1224–1231. doi:10.1093/carcin/bgm005.
34. Andreakos, E., B. Foxwell, and M. Feldmann. 2004. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation? Immunological Reviews 202: 250–265. doi:10.1111/j.0105-2896.2004.00202.x.
35. Jachak, S.M. 2006. Cyclooxygenase inhibitory natural products: current status. Current Medicinal Chemistry 13(6): 659–678.
36. Krakauer, T. 2004. Molecular therapeutic targets in inflammation: cyclooxygenase and NF-kappaB. Current Drug Targets. Inflammation and Allergy 3(3): 317–324.
37. Verma, N., S.K. Tripathi, D. Sahu, H.R. Das, and R.H. Das. 2010. Evaluation of inhibitory activities of plant extracts on production of LPS-stimulated pro-inflammatory mediators in J774 murine macrophages. Molecular and Cellular Biochemistry 336(1–2): 127–135. doi:10.1007/s11010-009-0263-6.
38. Mazzucchelli, L., C. Hauser, K. Zgraggen, H. Wagner, M. Hess, J.A. Laissue, et al. 1994. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. The American Journal of Pathology 144(5): 997–1007.
39. Ohshima, H., and H. Bartsch. 1994. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutation Research 305(2): 253–264.
40. Johnston, L.C., X. Su, K. Maguire-Zeiss, K. Horovitz, I. Ankoudinova, D. Guschin, et al. 2008. Human interleukin-10 gene transfer is protective in a rat model of Parkinson’s disease. Molecular Therapy: the Journal of the American Society of Gene Therapy 16(8): 1392–1399. doi:10.1038/mt.2008.113.
41. Arenzana-Seisdedos, F., J. Thompson, M.S. Rodriguez, F. Bachelerie, D. Thomas, and R.T. Hay. 1995. Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Molecular and Cellular Biology 15(5): 2689–2696.
42. Yoon, J.H., and S.J. Baek. 2005. Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Medical Journal 46(5): 585–596.
43. Azzolina, A., A. Bongiovanni, and N. Lampiasi. 2003. Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells. Biochimica et Biophysica Acta 1643(1–3): 75–83.
44. Lewis, T.S., P.S. Shapiro, and N.G. Ahn. 1998. Signal transduction through MAP kinase cascades. Advances in Cancer Research 74: 49–139.